Bayer lifts sales and earnings again
- Details
- Category: Bayer

Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer Responded to Crizotinib (PF-02341066)
- Details
- Category: Pfizer

Bristol-Myers Squibb Third Quarter Featured Solid Operating Performance
- Details
- Category: Bristol-Myers Squibb

Merck KGaA Profit After Tax Jumps 45% to EUR 215 Million
- Details
- Category: Merck Group

AstraZeneca initiates phase IIB study for AZD9773
- Details
- Category: AstraZeneca

FDA approves Herceptin for HER2-positive metastatic stomach cancer
- Details
- Category: Roche

Novartis delivers excellent performance in third quarter
- Details
- Category: Novartis

More Pharma News ...
- US FDA Approves Pradaxa® (dabigatran etexilate)
- Pfizer Enters Into Agreement to Acquire 40 Percent Stake in Teuto in Brazil
- Genzyme Reports Financial Results for the Third Quarter of 2010
- Genzyme Announces Results of Phase 3 Trial of Clolar
- Sanofi-aventis Establishes Research Collaboration with Harvard University
- Biocon and Pfizer Enter Into Global Commercialization Agreement
- Roche Group posts solid sales growth in first nine months